These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11354682)

  • 1. Construction of peptides with nucleobase amino acids: design and synthesis of the nucleobase-conjugated peptides derived from HIV-1 Rev and their binding properties to HIV-1 RRE RNA.
    Takahashi T; Hamasaki K; Ueno A; Mihara H
    Bioorg Med Chem; 2001 Apr; 9(4):991-1000. PubMed ID: 11354682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
    Sugaya M; Nishino N; Katoh A; Harada K
    J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV Rev peptides conjugated with peptide nucleic acids and their efficient binding to RRE RNA.
    Kumagai I; Takahashi T; Hamasaki K; Ueno A; Mihara H
    Bioorg Med Chem Lett; 2001 May; 11(9):1169-72. PubMed ID: 11354369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleobase amino acids incorporated into the HIV-1 nucleocapsid protein increased the binding affinity and specificity for a hairpin RNA.
    Takahashi T; Ueno A; Mihara H
    Chembiochem; 2002 Jun; 3(6):543-9. PubMed ID: 12325010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereospecificity of short Rev-derived peptide interactions with RRE IIB RNA.
    Litovchick A; Rando RR
    RNA; 2003 Aug; 9(8):937-48. PubMed ID: 12869705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
    Luedtke NW; Tor Y
    Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo design of peptides with L-alpha-nucleobase amino acids and their binding properties to the P22 boxB RNA and its mutants.
    Miyanishi H; Takahashi T; Mihara H
    Bioconjug Chem; 2004; 15(4):694-8. PubMed ID: 15264855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted cleavage of HIV RRE RNA by Rev-coupled transition metal chelates.
    Joyner JC; Cowan JA
    J Am Chem Soc; 2011 Jun; 133(25):9912-22. PubMed ID: 21585196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of HIV Rev peptides containing peptide nucleic acid that bind HIV RRE IIB RNA.
    Kumagai I; Takahashi T; Hamasaki K; Ueno A; Mihara H
    Bioorg Med Chem Lett; 2000 Feb; 10(4):377-9. PubMed ID: 10714504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular recognition of a branched peptide with HIV-1 Rev Response Element (RRE) RNA.
    Dai Y; Peralta AN; Wynn JE; Sherpa C; Li H; Verma A; Le Grice SFJ; Santos WL
    Bioorg Med Chem; 2019 Apr; 27(8):1759-1765. PubMed ID: 30879859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-triggered conformational switch in HIV-1 RRE RNA complexes.
    Gosser Y; Hermann T; Majumdar A; Hu W; Frederick R; Jiang F; Xu W; Patel DJ
    Nat Struct Biol; 2001 Feb; 8(2):146-50. PubMed ID: 11175904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of RSG-1.2 peptide binding to RRE-IIB RNA element of HIV-1 over Rev peptide is mainly enthalpic in origin.
    Kumar S; Bose D; Suryawanshi H; Sabharwal H; Mapa K; Maiti S
    PLoS One; 2011; 6(8):e23300. PubMed ID: 21853108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costabilization of peptide and RNA structure in an HIV Rev peptide-RRE complex.
    Tan R; Frankel AD
    Biochemistry; 1994 Dec; 33(48):14579-85. PubMed ID: 7981219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alpha-helical peptidomimetic inhibitor of the HIV-1 Rev-RRE interaction.
    Mills NL; Daugherty MD; Frankel AD; Guy RK
    J Am Chem Soc; 2006 Mar; 128(11):3496-7. PubMed ID: 16536504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molding a peptide into an RNA site by in vivo peptide evolution.
    Harada K; Martin SS; Tan R; Frankel AD
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11887-92. PubMed ID: 9342332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
    Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
    J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of artificial pepetides that recognize the HIV RRE IIB RNA.
    Takahashi T; Kumagai I; Hamasaki K; Ueno A; Mihara H
    Nucleic Acids Symp Ser; 1999; (42):271-2. PubMed ID: 10780484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA.
    Daly TJ; Doten RC; Rusche JR; Auer M
    J Mol Biol; 1995 Oct; 253(2):243-58. PubMed ID: 7563086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a Branched Peptide That Recognizes the Rev Response Element (RRE) RNA and Blocks HIV-1 Replication.
    Dai Y; Wynn JE; Peralta AN; Sherpa C; Jayaraman B; Li H; Verma A; Frankel AD; Le Grice SF; Santos WL
    J Med Chem; 2018 Nov; 61(21):9611-9620. PubMed ID: 30289719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of neomycin analogues for HIV-1 RRE RNA recognition identifies enhanced activity simplified neamine analogues.
    Simon B; Walmsley C; Jackson VJ; Garvey EP; Slater MJ; Berrisford DJ; Gardiner JM
    Bioorg Med Chem Lett; 2019 Jan; 29(2):339-341. PubMed ID: 30477891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.